NO20010620D0 - Vitronektinreseptor-antagonister - Google Patents

Vitronektinreseptor-antagonister

Info

Publication number: NO20010620D0
Authority: NO; Norway
Prior art keywords: receptor antagonists; vitronectin receptor; vitronectin; antagonists; receptor
Prior art date: 1998-08-07

Application number

NO20010620A

Other languages

English (en)

Other versions

NO20010620L (no

Inventor

Peter J Manley

William H Miller

Original Assignee

Smithkline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-07

Filing date

2001-02-06

Publication date

2001-02-06

2001-02-06 Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp

2001-02-06 Publication of NO20010620D0 publication Critical patent/NO20010620D0/no

2001-02-06 Publication of NO20010620L publication Critical patent/NO20010620L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Engineering & Computer Science (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20010620A 1998-08-07 2001-02-06 Vitronektinreseptor-antagonister NO20010620L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US9570398P	1998-08-07	1998-08-07
PCT/US1999/017665 WO2000007544A2 (en)	1998-08-07	1999-08-03	Vitronectin receptor antagonists

Publications (2)

Publication Number	Publication Date
NO20010620D0 true NO20010620D0 (no)	2001-02-06
NO20010620L NO20010620L (no)	2001-02-06

Family

ID=22253229

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20010620A NO20010620L (no)	1998-08-07	2001-02-06	Vitronektinreseptor-antagonister

Country Status (18)

Country	Link
US (1)	US6458814B1 (no)
EP (1)	EP1102587A4 (no)
JP (1)	JP2002522360A (no)
KR (1)	KR20010086355A (no)
CN (1)	CN1322133A (no)
AR (1)	AR020121A1 (no)
AU (1)	AU5336299A (no)
BR (1)	BR9912638A (no)
CA (1)	CA2339666A1 (no)
CO (1)	CO5170532A1 (no)
CZ (1)	CZ2001447A3 (no)
HU (1)	HUP0103090A3 (no)
IL (1)	IL141163A0 (no)
NO (1)	NO20010620L (no)
PL (1)	PL346157A1 (no)
TR (1)	TR200100363T2 (no)
WO (1)	WO2000007544A2 (no)
ZA (1)	ZA200100935B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9805655D0 (en)	1998-03-16	1998-05-13	Celltech Therapeutics Ltd	Chemical compounds
GB9826174D0 (en)	1998-11-30	1999-01-20	Celltech Therapeutics Ltd	Chemical compounds
EP1332132B1 (en)	2000-04-17	2007-10-10	UCB Pharma, S.A.	Enamine derivatives as cell adhesion molecules
JP2004511434A (ja)	2000-06-15	2004-04-15	ファルマシア・コーポレーション	インテグリン受容体アンタゴニストとしてのヘテロアリールアルカン酸
FR2847254B1 (fr) *	2002-11-19	2005-01-28	Aventis Pharma Sa	Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
US7115596B2 (en)	2002-12-20	2006-10-03	Pharmacia Corporation	Thiazole compounds as integrin receptor antagonists derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59108771A (ja) *	1982-12-13	1984-06-23	Taiho Yakuhin Kogyo Kk	オキサゾール誘導体
FI922867A7 (fi)	1991-06-21	1992-12-22	Tanabe Seiyaku Co	Dikarbonsyraderivat och foerfarande foer framstaellning av dem
ES2134870T3 (es) *	1993-05-01	1999-10-16	Merck Patent Gmbh	Antagonistas del receptor de adhesion.
US5756466A (en) *	1994-06-17	1998-05-26	Vertex Pharmaceuticals, Inc.	Inhibitors of interleukin-1β converting enzyme
PL318199A1 (en) *	1994-06-29	1997-05-26	Smithkline Beecham Corp	Antagonists of vitronectin receptors

1999
- 1999-08-03 US US09/762,406 patent/US6458814B1/en not_active Expired - Fee Related
- 1999-08-03 KR KR1020017001583A patent/KR20010086355A/ko not_active Withdrawn
- 1999-08-03 PL PL99346157A patent/PL346157A1/xx not_active Application Discontinuation
- 1999-08-03 BR BR9912638-9A patent/BR9912638A/pt not_active Application Discontinuation
- 1999-08-03 CZ CZ2001447A patent/CZ2001447A3/cs unknown
- 1999-08-03 CA CA002339666A patent/CA2339666A1/en not_active Abandoned
- 1999-08-03 TR TR2001/00363T patent/TR200100363T2/xx unknown
- 1999-08-03 IL IL14116399A patent/IL141163A0/xx unknown
- 1999-08-03 CN CN99811933A patent/CN1322133A/zh active Pending
- 1999-08-03 AU AU53362/99A patent/AU5336299A/en not_active Abandoned
- 1999-08-03 JP JP2000563230A patent/JP2002522360A/ja not_active Withdrawn
- 1999-08-03 EP EP99938993A patent/EP1102587A4/en not_active Withdrawn
- 1999-08-03 HU HU0103090A patent/HUP0103090A3/hu unknown
- 1999-08-03 WO PCT/US1999/017665 patent/WO2000007544A2/en not_active Ceased
- 1999-08-05 AR ARP990103914A patent/AR020121A1/es unknown
- 1999-08-06 CO CO99049955A patent/CO5170532A1/es not_active Application Discontinuation
2001
- 2001-02-02 ZA ZA200100935A patent/ZA200100935B/en unknown
- 2001-02-06 NO NO20010620A patent/NO20010620L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20010086355A (ko)	2001-09-10
WO2000007544A3 (en)	2000-05-18
TR200100363T2 (tr)	2001-06-21
AR020121A1 (es)	2002-04-10
BR9912638A (pt)	2001-05-02
EP1102587A4 (en)	2003-03-12
HUP0103090A3 (en)	2002-12-28
EP1102587A2 (en)	2001-05-30
US6458814B1 (en)	2002-10-01
ZA200100935B (en)	2002-05-14
CZ2001447A3 (cs)	2001-08-15
JP2002522360A (ja)	2002-07-23
NO20010620L (no)	2001-02-06
CO5170532A1 (es)	2002-06-27
AU5336299A (en)	2000-02-28
CA2339666A1 (en)	2000-02-17
CN1322133A (zh)	2001-11-14
PL346157A1 (en)	2002-01-28
WO2000007544A2 (en)	2000-02-17
HUP0103090A2 (hu)	2002-01-28
IL141163A0 (en)	2002-02-10

Publication	Publication Date	Title
DK0957917T3 (da)	2006-04-18	Vitronectinreceptorantagonister
NO993350D0 (no)	1999-07-07	Vitronectin-reseptor-antagonister
NO965608D0 (no)	1996-12-27	Vitronectin-reseptor-antagonister
DE69921351D1 (de)	2004-11-25	4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii
IS5706A (is)	2000-11-07	Adenosín A3 viðtakastillar
DE69812096D1 (de)	2003-04-17	Neuropeptid y rezeptorantagonisten
CY2010003I1 (el)	2012-01-25	Αγωνιστες των βητα-2 αδρενεργικων υποδοχεων
NO20004503D0 (no)	2000-09-08	Vitronectin-reseptor-antagonister
ID24726A (id)	2000-08-03	Antagonis-antagonis reseptor trombin
NO20001514D0 (no)	2000-03-23	Vitronectin-reseptor-antagonist
NO20001407D0 (no)	2000-03-17	Vitronectin-reseptor-antagonister
NO20001515D0 (no)	2000-03-23	Vitronektin reseptor-antagonist
NO20016053L (no)	2001-12-11	IL-8 reseptor-antagonister
ATE277043T1 (de)	2004-10-15	Vitronectin rezeptor antagonist
NO20016052L (no)	2001-12-11	IL-8-reseptor-antagonister
DK1180028T3 (da)	2007-05-21	IL-8-receptorantagonister
NO20021113D0 (no)	2002-03-06	Vitronectin-reseptor-antagonister
NO20015774L (no)	2001-11-27	IL-8 reseptorantagonister
NO20010620D0 (no)	2001-02-06	Vitronektinreseptor-antagonister
DK1218005T3 (da)	2005-04-11	Vitronectinreptorantagonister
NO20016102L (no)	2002-02-12	IL-8 reseptorantagonister
NO20016065L (no)	2001-12-12	IL-8-reseptor-antagonister
DE69830671D1 (de)	2005-07-28	Integrin-rezeptor-antagonisten

Legal Events

Date	Code	Title	Description
2003-04-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application